These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer. Hińcza-Nowak K; Kowalik A; Walczyk A; Pałyga I; Gąsior-Perczak D; Płusa A; Kopczyński J; Chrapek M; Góźdź S; Kowalska A Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373167 [TBL] [Abstract][Full Text] [Related]
3. A Case Report of Sequential Use of a Yeast-CEA Therapeutic Cancer Vaccine and Anti-PD-L1 Inhibitor in Metastatic Medullary Thyroid Cancer. Del Rivero J; Donahue RN; Marté JL; Gramza AW; Bilusic M; Rauckhorst M; Cordes L; Merino MJ; Dahut WL; Schlom J; Gulley JL; Madan RA Front Endocrinol (Lausanne); 2020; 11():490. PubMed ID: 32849281 [TBL] [Abstract][Full Text] [Related]
5. Modulatory Role of Single Nucleotide Polymorphisms of Distinct Genetic Pathways on Clinical Behavior of Medullary Thyroid Carcinoma. Mishra V; Kowtal P; Rane P; Sarin R Asian Pac J Cancer Prev; 2020 May; 21(5):1289-1293. PubMed ID: 32458635 [TBL] [Abstract][Full Text] [Related]
6. Epigenetics in Medullary Thyroid Cancer: From Pathogenesis to Targeted Therapy. Vitale G; Dicitore A; Messina E; Sciammarella C; Faggiano A; Colao A Recent Pat Anticancer Drug Discov; 2016; 11(3):275-82. PubMed ID: 27306881 [TBL] [Abstract][Full Text] [Related]
7. Quantitative Proteomics Analysis of Sporadic Medullary Thyroid Cancer Reveals FN1 as a Potential Novel Candidate Prognostic Biomarker. Zhan S; Li J; Wang T; Ge W Oncologist; 2018 Dec; 23(12):1415-1425. PubMed ID: 29739896 [TBL] [Abstract][Full Text] [Related]
8. Sorafenib in Japanese Patients with Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma. Ito Y; Onoda N; Ito KI; Sugitani I; Takahashi S; Yamaguchi I; Kabu K; Tsukada K Thyroid; 2017 Sep; 27(9):1142-1148. PubMed ID: 28635560 [TBL] [Abstract][Full Text] [Related]
9. Fine-needle aspiration cytology for medullary thyroid carcinoma: a single institutional experience in Japan. Suzuki A; Hirokawa M; Takada N; Higuchi M; Ito A; Yamao N; Hayashi T; Kuma S; Miyauchi A Endocr J; 2017 Nov; 64(11):1099-1104. PubMed ID: 28883261 [TBL] [Abstract][Full Text] [Related]
10. Histopathology of C Cells and Medullary Thyroid Carcinoma. Schmid KW Recent Results Cancer Res; 2015; 204():41-60. PubMed ID: 26494383 [TBL] [Abstract][Full Text] [Related]
11. Surufatinib in Chinese Patients with Locally Advanced or Metastatic Differentiated Thyroid Cancer and Medullary Thyroid Cancer: A Multicenter, Open-Label, Phase II Trial. Chen J; Ji Q; Bai C; Zheng X; Zhang Y; Shi F; Li X; Tang P; Xu Z; Huang R; Huang T; Pan Y; Fan S; Zhou J; Su W Thyroid; 2020 Sep; 30(9):1245-1253. PubMed ID: 32075524 [No Abstract] [Full Text] [Related]